ThinkEquity Downgrades Nektar Therapeutics (NKTR) to Sell, Reaffirms $5 Price Target Jan 17, 2012 07:56AM
ThinkEquity Downgrades Nektar Therapeutics (NKTR) to Hold Feb 15, 2011 08:00AM
Notable Analyst Rating Changes 06/09: EQIX, POT, BTU, VALE Upgraded; EVVV, RST, FFIV, WTNY Downgraded Jun 9, 2010 11:01AM